- Research works
- 57 ▲ 214% vs 2018-21
- Citations
- 261 4.6 per fractional work
- Top-10% rate
- 4.1% all institutions 10.0%
- Open access
- 33% world 40%
- International
- 12% world 18%
Not ranked overall: Hansoh Pharma (China) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Hansoh Pharma (China) work in?
In 2022-now, 53% of research at Hansoh Pharma (China) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (18%), Chemistry (11%). It does 1.8× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 17 fields, with their numbers
- Health Sciences1352.6%
- Medicine1251.8%
- Dentistry00.5%
- Health Professions00.3%
- Life Sciences625.5%
- Physical Sciences520.8%
- Chemistry311.4%
- Engineering15.7%
- Mathematics01.6%
- Environmental Science01.0%
- Materials Science00.5%
- Computer Science00.3%
- Energy00.2%
- Social Sciences01.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.7×. Every wedge is a field page.
All 17 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics12.68×1 works
- Chemistry7.29×3 works
- Biochemistry, Genetics and Molecular Biology3.34×4 works
- Medicine2.69×12 works
- Mathematics1.38×0 works
- Dentistry0.96×0 works
- Immunology and Microbiology0.88×0 works
- Neuroscience0.45×0 works
- Economics, Econometrics and Finance0.44×0 works
- Engineering0.38×1 works
- Agricultural and Biological Sciences0.34×0 works
- Energy0.22×0 works
- Environmental Science0.21×0 works
- Materials Science0.13×0 works
- Health Professions0.13×0 works
- Psychology0.06×0 works
- Computer Science0.03×0 works
- Pharmacology, Toxicology and Pharmaceutics 12.7×
- Chemistry 7.3×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 2.7×
- Mathematics 1.4×
- Dentistry 1.0×
- Immunology and Microbiology 0.9×
- Neuroscience 0.5×
- Economics, Econometrics and Finance 0.4×
- Engineering 0.4×
- Agricultural and Biological Sciences 0.3×
- Energy 0.2×
- Environmental Science 0.2×
- Materials Science 0.1×
- Health Professions 0.1×
- Psychology 0.1×
- Computer Science 0.0×
Who are the top researchers at Hansoh Pharma (China)?
Ranked on the quality score, Yunfan Li, Jeffrey Jasper and Wang Chun-ling lead among researchers whose main affiliation is Hansoh Pharma (China).
- 1
Yunfan Li
China · #1,943,979 worldwide 246 citations · 40 works
- 2
Jeffrey Jasper
China · #4,302,311 worldwide 230 citations · 15 works
- 3
Wang Chun-ling
China · #4,898,698 worldwide 2 citations · 22 works
Which keywords describe research at Hansoh Pharma (China)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Clinical Trials, Chemotherapy, Genomic Profiling, ALK Inhibitors, EGFR Mutations, Chronic Kidney Disease and Monoclonal Antibody.
- Recombinant Protein
- Epidemiology
- Monoclonal Antibodies
- Prognostic Factors
- Heart Failure
- Chronic Kidney Disease
- EGFR Mutations
- Genomic Profiling
- Chemotherapy
- Targeted Therapy
- Clinical Trials
- ALK Inhibitors
- Cardiovascular Disease
- Monoclonal Antibody
- Glycosylation
- Biomarkers
- Cell Culture
- Mammalian Cells
- Synthesis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Targeted Therapy3▲ 54×3 topics
- Chemotherapy3▲ 15×8 topics
- Clinical Trials3▲ 17×5 topics
- Genomic Profiling2▲ 80×2 topics
- ALK Inhibitors2▲ 131×1 topic
- EGFR Mutations2▲ 131×1 topic
- Cardiovascular Disease2▲ 6.1×8 topics
- Chronic Kidney Disease2▲ 27×5 topics
- Monoclonal Antibody2▲ 123×2 topics
- Heart Failure2▲ 14×3 topics
- Glycosylation1▲ 46×2 topics
- Prognostic Factors1▲ 11×4 topics
- Biomarkers1▲ 6.8×7 topics
- Monoclonal Antibodies1▲ 50×3 topics
- Cell Culture1▲ 37×2 topics
- Epidemiology1◆ 1.07×9 topics
- Mammalian Cells1▲ 183×1 topic
- Recombinant Protein1▲ 183×1 topic
- Synthesis1▲ 11×4 topics
Which research topics does Hansoh Pharma (China) publish most on?
By volume in 2022-now: Lung Cancer Treatments and Mutations, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability and Erythropoietin and Anemia Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 3 Protein purification and stability Molecular Biology 1 works
- 4 Erythropoietin and Anemia Treatment Hematology 1 works
- 5 HER2/EGFR in Cancer Research Oncology 1 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 7 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
- 8 Lung Cancer Research Studies Oncology 0 works
- 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 10 Protein Degradation and Inhibitors Molecular Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Hansoh Pharma (China)'s research output changed?
Output in 2022-2025 was 214% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Hansoh Pharma (China) as a percentage of every work published that year, 0.00011% in 2024.
Fractional works of Hansoh Pharma (China) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Lianyun
- The First People’s Hospital of Lianyungang
- Kanion Pharmaceutical (China)
- Lianyungang Maternal and Children’s Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Hansoh Pharma (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.